Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis

Background: Cisplatin-based combination chemotherapy is standard treatment for metastatic urothelial carcinoma; however, the vast majority of patients experience disease progression. As systemic therapy alone is rarely curative for the treatment of metastatic urothelial cancer, not only are new ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Vaibhav, Collazo Lorduy, Ana, Stern, Aaron, Fahmy, Omar, Pinotti, Rachel, Galsky, Matthew D., Gakis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409038/
https://www.ncbi.nlm.nih.gov/pubmed/28516157
http://dx.doi.org/10.3233/BLC-170108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409038/
https://www.ncbi.nlm.nih.gov/pubmed/28516157
http://dx.doi.org/10.3233/BLC-170108

Ejemplares similares